In comments filed in response to a request for information from the Food and Drug Administration on increasing access to non-prescription drugs, NCPA made suggestions for conditions and types of drugs that could be administered as non-prescription drugs safely and effectively without the supervision of a licensed health care practitioner, and for those that should not be administered as non-prescription without the supervision of a licensed health care practitioner. For details, see our comment letter here.
Additionally, we stressed that ideally, any non-prescription class of drugs should leverage the expertise of the pharmacist by being available only from state-licensed pharmacies where pharmacists can assist with the necessary assessment processes for determining whether a particular medication is appropriate for the individual seeking the therapy.
